Table 1 Baseline characteristics
Total (n = 62) | |
|---|---|
Age (years) | 59 (27–81) |
Sex | |
Male | 45 (72.6%) |
Female | 17 (27.4%) |
Race | |
Asian | 62 |
ECOG performance status | |
0 | 9 (14.5%) |
1 | 53 (85.5%) |
Primary tumor site | |
Cardia | 6 (9.7%) |
Body | 31 (50.0%) |
Antrum | 25 (40.3%) |
Tumor grade | |
Well-differentiated adeno | 3 (4.8%) |
Moderately differentiated | 17 (27.4%) |
Poorly differentiated | 22 (35.5%) |
Signet ring cell type | 20 (32.3%) |
Disease status | |
Recurrent after surgery | 5 (8.1%) |
Metastatic at diagnosis | 57 (91.9%) |
Number of metastatic sites | |
1 organ | 16 (25.8%) |
≥ 2 organs | 46 (74.2%) |
HER2 positivity | 10 (16.1%) |
EBV positivity | 3 (4.8%) |
MSS | 62 (100.0%) |